Dow Up1.33% Nasdaq Up1.33%

Synthetic Biologics Inc. (SYN)

-NYSE MKT
1.80 Up 0.02(1.12%) 4:02PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development32,906  14,489  6,507  
Selling General and Administrative8,074  6,013  5,832  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (40,980) (20,502) (12,339)
Income from Continuing Operations
Total Other Income/Expenses Net(3,805)718  21  
Earnings Before Interest And Taxes(44,785)(19,784)(12,318)
Interest Expense -   -   -  
Income Before Tax(44,785)(19,784)(12,318)
Income Tax Expense -   -   -  
Minority Interest1,048   -  1  
Net Income From Continuing Ops(43,737)(19,784)(12,317)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (43,737) (19,784) (12,317)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (43,737) (19,784) (12,317)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.